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A B S T R A C T   
Background and aims: Previously, we determined that training with vibrotactile feedback (VTfb) of trunk sway 
improves MS patients’ balance impairment. Here, we posed 5 questions: 1) How many weeks of VTfb training are 
required to obtain the best short-term carry over effect (CoE) with VTfb? 2) How long does the CoE last once 
VTfb training terminates? 3) Is the benefit similar for stance and gait? 4) Is position or velocity based VTfb more 
effective in reducing trunk sway? 5) Do patients’ subjective assessments of balance control improve? 
Methods: Balance control of 16 MS patients was measured with gyroscopes at the lower trunk. The gyroscopes 
drove directionally active VTfb in a head-band. Patients trained twice per week with VTfb for 4 weeks to 
determine when balance control with and without VTfb stopped improving. Thereafter, weekly assessments 
without VTfb over 4 weeks and at 6 months determined when CoEs ended. 
Results: A 20% improvement in balance to normal levels occurred with VTfb. Short term CoEs improved from 15 
to 20% (p ≤ 0.001). Medium term (1–4 weeks) CoEs were constant at 19% (p ≤ 0.001). At 6 months 
improvement was not significant, 9%. Most improvement was for lateral sway. Equal improvement occurred 
when angle position or velocity drove VTfb. Subjectively, balance improvements peaked after 3 weeks of training 
(32%, p ≤ 0.05). 
Conclusions: 3–4 weeks VTfb training yields clinically relevant sway reductions and subjective improvements for 
MS patients during stance and gait. The CoEs lasted at least 1 month. Velocity-based VTfb was equally effective 
as position-based VTfb.   
1. Introduction 
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and 
neurodegenerative disease of the central and peripheral nervous systems 
[1,2]. In 2013, the number of individuals with MS was estimated to be 
2.3 million worldwide [3]. In Switzerland, recent epidemiological esti-
mates indicate that there are approximately 15,000 individuals with MS 
[4,5]. 
It is a general finding across several studies that MS patients have 
impaired balance control [6]. Given the individually highly variable 
disease-course [7], these balance deficits can arise from combinations of 
neurological deficits, such as paresis, spasticity, decreased somatosen-
sory proprioception, cerebellar disorders, visual impairment, cognitive 
impairments and fatigue [8–11]. 
Cameron & Lord [12] described the most impacting challenges of 
balance control in patients with MS as (i) a difficulty maintaining the 
same position without increased sway; (ii) difficulties in moving to the 
limits of stability; (iii) leaning or moving while standing on one leg, and, 
(iv) slowed reactions to postural disturbances. These difficulties lead to 
slower gait speed, presumably as an attempt to reduce roll sway [13], 
and an increase in falls [12]. As an example of the slowed reactions, 
Cameron and colleagues [9] investigated the relationship between 
automatic postural response latencies (reaction times) to support surface 
perturbations and leg afferent nerve transmission times quantified using 
somatosensory evoked potential (SSEP) latencies from the stimulation 
point at the ankle to the recording location at the spinal cord or cerebral 
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cortex. It was demonstrated that the automatic postural response la-
tencies were delayed for MS patients and this delay was positively 
correlated with increased SSEP latencies. Furthermore, ankle torque 
response amplitudes were increased to compensate for the increased 
postural response latency. The data of Cameron et al. [9] indicates that 
one reason pathological responses to balance disturbances occur in in-
dividuals with MS is due to a slowed afferent conduction to the central 
nervous system (CNS) of the proprioceptive signals contributing to 
balance control. However, reduced efferent input can also result in 
slowed and weakened reactions to correct individual balance instability 
[9]. In addition, it is possible that weakened gamma efferent inputs to 
muscle spindles also effect the sensitivity of afferent fibres to muscle 
stretch [14]. 
The findings above suggest that the natural feedforward and feed-
back balance control systems are altered in MS, leading to slowed 
proprioceptive-based reaction times and weakened responses. An arti-
ficial external feedback system could provide faster perception of 
movement than compromised natural systems and thereby help improve 
the balance control of individuals with MS. One possible approach, 
which was first used for peripheral vestibular loss subjects who had 
failed to compensate for their reduced balance control, would be to 
provide vibrotactile feedback (VTfb) of trunk sway [15,16]. The 
advantage of the VTfb technique is that the threshold of body sway can 
be set so that an earlier, enhanced conscious perception of movement is 
signalled by the onset of tactile vibration. The tactile sensations are 
transmitted to the brain over afferent fibres [17] from locations where 
the vibrators are placed, such as the waist [18] or head [19], that is, 
where tactile sensation is often less affected by MS. In bilateral vestib-
ular loss subjects, it has been shown that VTfb reduces sway as a result of 
these subjects learning to reduce co-activation levels in trunk and leg 
muscles to levels of healthy controls [20]. 
Given that improvements in MS patients’ reaction times might occur 
with VTfb in a similar manner to healthy individuals [19], a number of 
issues need to be considered. These include whether use of VTfb presents 
a test subject with a dual task, i.e. reducing their ability to concentrate 
on natural afferent signals and whether position or velocity feedback 
signals should be used for stance and gait tasks, respectively [21]. From 
a clinical viewpoint it is important to quantify the duration of the VTfb 
training that is necessary to obtain a maximal effect on balance control, 
and the time period over which any subsequent carry-over effect (the 
effect on balance control after VTfb training ceases) remains present. 
This information would provide a guideline for determining the time 
when a patient should return to his/her responsible therapy centre for 
additional training with VTfb and forms the major focus of this study. 
Our assumption, based on patient comments, is that patients would 
prefer this type of rehabilitation based on a carry-over effect in com-
parison to one where they would need to wear the possibly cosmetically 
disturbing VTfb equipment continuously. 
In randomized cross-over studies, the effect of training sessions with 
and without VTfb was determined for MS patients [22], as well as for 
young and elderly heathy individuals [19]. In these studies, the biggest 
improvements in trunk sway were always demonstrated when partici-
pants received the training with feedback and were tested with feedback 
[19,22]. 
The aforementioned question of the effect sensory augmentation has 
on dual tasking (assuming that paying attention to the VTfb represents a 
dual task) has been investigated for young and elderly healthy adults. 
Verhoeff et al. [23] found that young adults could reduce sway using 
VTfb during normal walking, both with and without an additional 
cognitive or motor dual task. Elderly individuals could likewise reduce 
sway during walking both with and without an additional motor task but 
not during an additional cognitive task. We assumed that this result 
observed with the elderly would be similar, in the worst case, for the 
middle-aged MS patients aged about 54 years of the current study. For 
MS patients, other authors, e.g. Prosperini et al. [24], have found that 
most simultaneously performed dual tasks have little effect on balance 
control even though stance balance control was worse in MS patients 
compared to healthy controls. Based on these results we assumed that 
paying attention to the VTfb during stance and gait trials could not be 
considered a cognitive dual task limiting balance task abilities and, if it 
were, there would not be an effect on the improvements in balance 
control. 
The vibrotactile sensory augmentation technique has been investi-
gated for a variety of patient groups, including those with vestibular loss 
[25]. With the exception of our studies [22], this technique has not yet 
been applied to patients with MS. Most studies propose that the VTfb 
device should be worn continuously, thereby not incorporating the 
possibility of learning and adaptation effects present as carry-over ef-
fects in the treatment procedure. 
In our recent study, Rust et al. [26] demonstrated that in MS patients 
two weeks of training with VTfb of trunk sway led in the first week to a 
rapid improvement in balance control followed by an additional slightly 
improved balance control in the second week of VTfb training. There 
was also a carry-over effect present 2 weeks after the training had ended, 
indicating that both training and carry-over effects might continue to 
improve further with a longer VTfb training period. Therefore, the aim 
of the current study was to determine the effect on balance control of 
four weeks of VTfb training. Our primary interest was to plot the time 
course of the slower secondary balance control improvement with VTfb 
training and the time course of reduction of the carry-over effect once 
VTfb training ceased, given that balance training with VTfb provides a 
greater improvement in balance control than balance training without 
VTfb [22]. Information on these time courses would provide relevant 
clinical information regarding when to retrain patients once the carry- 
over effect was no longer present. In addition, the training assessment 
procedure we describe below and in Figure 2 was used in an attempt to 
answer the question whether the carry-over effect of 8 sessions of 
training with VTfb is so strong that continuous wear of the VTfb system 
for improved balance control would not become necessary. Rather, pa-
tients would only need to re-train for 1–2 weeks with VTfb once the 
carry-over effect had worn off. The advantage of the technique used in 
this study is the simplicity of the feedback, which is directly related to 
movements of the body’s centre of gravity, and the placement of the 
VTfb at the head. We assumed the VTfb acts as a sensory augmentation 




The protocol of this interventional study was approved by the local 
ethics committee (Approval 2014-026 Ethical Committee of North-West 
and Central Switzerland). All participants provided prior written 
informed consent to participate in the study. None of the patients had 
participated in previous studies [22,26] examining the effects of VTfb on 
Fig. 1. A Schematic of the spacing of the vibrators in the vibrotactile feedback 
head-band. B Photograph of the head band as worn by the study subjects. 
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balance control. All 16 participants were recruited from the neurological 
outpatient clinic of the University of Basel Hospital, Switzerland. Eleven 
of the 16 patients were female and 5 patients were male, 13 had 
relapsing-remitting MS, and 3 suffered from primary-progressive MS. 
The mean patient age was 54.3 ± 7.1 years, the median Expanded 
Disability Status Scale (EDSS) score was 3.0 [range 2.5–4.0], and mean 
disease duration was 12.7 ± 9.1 years. Study inclusion criteria were the 
diagnosis of MS according to the revised McDonald criteria from 2010 
[27], nonexistence of a relapse during the last 6 months before study 
entry, subjectively reported restrictions to balance, and quantified def-
icits in balance control as noted during the first assessment (for details, 
see below). Participants were excluded if they were not able to walk 8 m 
without walking aids, or had conditions other than MS that might have 
affected balance (e.g. vestibular impairment, orthopaedic disorders, and 
severe comorbidities) or had noticeable cognitive or psychiatric distur-
bances that might have or proved to have affected testing. Table 1 de-
scribes the patients’ neurological characteristics and disease modifying 
treatment. The number of patients recruited, 16, was guided by our 
previous study involving 15 patients for whom a significant effect of 
VTfb on balance control was noted after 1 week of VTfb training [26] as 
in the current study. 
Participant sensed restrictions in balance control during daily life 
were estimated using the Dizziness Handicap Inventory (DHI) [28] and 
the 12-item Multiple Sclerosis Walking Scale (MSWS-12) [29] ques-
tionnaires. The DHI consists of 25 questions designed to quantify the 
subjectively experienced balance deficit. It has demonstrated appro-
priate reliability and content validity when completed by MS patients 
[30]. High DHI scores suggest a high subjectively experienced disability. 
The MSWS-12 is a validated subjective assessment of the walking ability 
of MS patients [29]. Balance control was measured with a SwayStar™ 
system (Balance International Innovations GmbH, Switzerland) which 
contains two fibre-optic gyroscopes mounted on a converted motor cycle 
kidney belt. These were aligned to measure lower trunk pitch (anterior- 
posterior sway) and roll (medial-lateral sway) angular velocities. The 
velocities were sampled at 100 Hz and then transferred to a computer 
using Bluetooth™ communication. Pitch and roll angles are computed 
on-line using trapezoid integration of the velocity samples. Prior to 
participating in the study, subjects underwent a comprehensive clinical 
neurological examination which included screening for inclusion and 
exclusion criteria. 
2.2. Intervention 
Vibrotactile feedback (VTfb) of trunk sway was provided to study 
participants using an add-on device of Swaystar called Balance 
Freedom™. This feedback system consists of 8 vibrators positioned at 
45-degree intervals around a circular head band providing directionally 
specific sway information (see Fig. 1). For example, if a sway threshold 
for forward pitch was exceeded, the vibrator in the middle of the fore-
head was activated. Likewise, for backward movement exceeding 
threshold, the vibrator at the back of the head came on. Left and right 
supra-threshold sway caused the vibrators over the left and right ears, 
respectively, to be activated. For sway in the diagonal directions, for-
ward and left, for example, the vibrator between the forehead and left 
ear vibrators was activated when its threshold was exceeded. Thus when 
the head was aligned in the head straight-ahead position, the vibro-
tactile feedback (VTfb) provided by the vibrators was aligned with the 
axes of the gyroscopes. The controller for the vibrators was connected 
directly with the SwayStar™ unit (see cable in Fig. 1B). Task-specific 
thresholds for trunk sway angles (used during stance and tandem steps 
tasks) and angular velocities (used during gait tasks plus an additional 
tandem steps task) were set in the controller based on pitch and roll 
measures obtained from the first (baseline) assessment and successively 
readjusted based on measures from the 3rd, 5th, and 7th assessments 
(see Fig. 2). The threshold VTfb amplitudes were calculated as 40% of 
the 90% ranges of pitch and roll sway angle or angular velocity. We used 
40% of the 90% ranges based on a previous assessment of the average 
range of sway reductions achieved by healthy elderly and young normal 
subjects [19,22]. Thus, the threshold ranges were set at 80% (40% for 
each side) of the 90% ranges. To determine the 90% ranges, the total 
peak-to-peak range of each trunk sway variable was determined over the 
trial duration for a task and this range split into 40 bins. Samples were 
then sorted into the appropriate bins to build a histogram of the samples. 
The range from the lower 5% and the upper 95% of the histogram was 
used to define the 90% range. The thresholds were individually set for 
each task. 
2.3. Procedure 
Over a period of 4 weeks, all participants performed a series of 
assessment and training sequences of gait and stance tasks. The order of 
assessments and training sessions is presented in Fig. 2. The study 
Table 1 
Patient neurological characteristics. The following abbreviations have been used: MS, multiple sclerosis; RRMS, relapsing remitting multiple sclerosis; PPMS, primary 
progressive multiple sclerosis; EDSS, expanded disability status scale; LRE, lower right extremity; LLE, lower left extremity; BLE, both lower extremities; M, motor 















1 RRMS 10 3.0 Slight cerebellar syndrome, motor fatigue 26 22 Natalizumab 
2 PPMS 8 3.5 Paraparesis, hip flexion LLE M4/5 40 46 Ocrelizumab 
3 PPMS 7 3.0 Slight tetraparesis, mild cerebellar syndrome 54 30 Ocrelizumab 
4 PPMS 6 2.5 Slight cerebellar syndrome and motor fatigue 8 20 Ocrelizumab 
5 RRMS 34 2.0 Paraparesis, hip flexion both LE M4/5 30 28 Fingolimod 
6 RRMS 23 4.0 Paraparesis, hip flexion both LE M4/5, knee flexion both LE M4/5, foot 
elevation LLE M4/5, slight affection of proprioception BLE 
22 24 Leflunomid 
7 RRMS 30 4.0 Paraparesis, LLE pronounced, hip and knee flexion LLE M4/5 28 35 Fingolimod 
8 RRMS 4 2.5 Slight tetraparesis, motor fatigue 44 24 Fingolimod 
9 RRMS 6 3.0 Paraparesis, hip flexion RLE M4/5, discrete residual paresis LLE 28 35 Ocrelizumab 
10 RRMS 24 3.5 Spastic paraparesis, hip flexion BLE M4+/5, moderate affection of 
proprioception BLE 
66 38 No DMT 
11 RRMS 12 4.0 Spastic paraparesis, hip and knee flexion BLE M4/5, foot elevation RLE M3/ 
5 
16 45 Ocrelizumab 
12 RRMS 8 3.5 Spastic paraparesis, mainly RLE pronounced, M 4/5 42 43 Ocrelizumab 
13 RRMS 16 4.0 Spastic paraparesis, M4/5 BLE, LLE > RLE 54 40 Fingolimod 
14 RRMS 23 3.0 Paraparesis RLE > LLE M4+/5 18 16 Ocrelizumab 
15 RRMS 13 3.0 Paresis RLE M4+/5 22 24 No DMT 
16 RRMS 17 2.5 Slight cerebellar syndrome, motor fatigue, moderate affection of 
proprioception BLE 
8 15 Tecfidera  
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procedure consisted of 2 phases: first, an intervention (i.e. training) 
phase during weeks 1 to 4 when training with VTfb of trunk sway was 
provided and; second, a phase, monitoring the decrease in the carry-over 
effect every week for 4 weeks and at 6 months after VTfb training had 
ceased. For 4 subjects we also monitored the carry-over effect at 2 and 4 
months after training ceased. The assessments during the carry-over 
monitoring phase were all performed without VTfb. During the 
training phase, assessments without VTfb were always carried out on 
Mondays. The assessments without VTfb were used to set (week 1) and 
reset (weeks 2–4) the VTfb thresholds for the training with VTfb. The 
VTfb device was not worn as a placebo during these assessments. In 
weeks 2–4, the assessment on Monday was also used to assess the short 
term (3 days) carry-over effect of VTfb training. Training with VTfb was 
performed on Wednesdays and Fridays during weeks 1 to 4. During 
training each task was performed 5 times. The training with VTfb 
occurred before the assessments with VTfb on Fridays of weeks 1 to 4 
(see Fig. 2). For weeks 1 to 4 the assessments on Fridays with VTfb 
provided information on whether on-line VTfb after training with VTfb 
aided balance control more than the carry-over effect. Training sessions 
lasted approximately 30 min and assessment sessions 15 min. A break of 
5 min was provided between training and assessment on Fridays to avoid 
fatigue. Assessments 1, 3, 5 and 7 in weeks 1 to 4, respectively, were 
performed with no VTfb and assessments 2, 4, 6 and 8 in the same weeks 
with VTfb. All of the following assessments [9 to 12] were without VTfb 
(see Fig. 2). We estimated the time course of the medium-term carry- 
over effect from the assessments 9 to 12 using simple regression analysis. 
The estimated values of projected balance control at 6 months post 
training were different from the actual assessment values at 6 months. 
However, the values of our primary balance measure (BCI- for definition 
see below) at 6 months were also not significantly different from base-
line measures (Fig. 3C). Therefore, we introduced additional examina-
tions at 2 and 4 months for the last 4 patients we tested in order to obtain 
a preliminary estimate of the earliest time-point when the carry-over 
effect was no longer present. 
2.4. Rationale for total duration of VTfb training and assessment sessions 
The current study was designed to determine the characteristics of 
improvements in balance control during VTfb training and subsequent 
carry-over effects once training sessions were terminated. In a previous 
study [22] we investigated the greater improvement in balance control 
with VTfb compared with training alone (without VTfb) for MS patients 
in a randomized cross-over study. Therefore, no comparison was made 
of the effect of training without VTfb in this study. In another prior 
study, Rust et al. [26] noted that the training and carry-over observation 
periods were too short, with 2 weeks, to describe the time-course 
characteristics of short-term carry-over effects after the initial 
improvement in the first week of training. Therefore, for the current 
study, the total duration of VTfb training and assessments sessions was 
extended to 4 weeks with 4 weeks of weekly follow-up. We expected a 
similar initial improvement in balance control with VTfb as in the pre-
vious studies [22,26] followed by a marked continuous improvement 
over the 4 weeks of training accompanied by an improvement in the 
subjectively experienced balance deficit as noted in the DHI question-
naires. In contrast, we expected the medium-term carry-over effect on 
balance control and DHI values to worsen during the 4 weeks post 
training at the same rate as the preceding short-term improvement. 
2.5. Assessment and training tasks 
The same 11 tasks were used for the assessments and training ses-
sions (Table 2). Selection of tasks was based on protocols developed by 
Tinetti [31] and Shumway-Cook and Horak [32] as well as our previous 
studies, which indicated the ability of these tasks to determine the 
presence of subclinical balance disorders in MS patients [33,34]. As-
sessments and training were always performed without shoes to avoid 
measurement variations due to shoe types. To avoid diurnal differences 
in fatigue levels affecting the results, assessments and training were 
always performed at the same preferred time of the day for each patient. 
For two-legged stance tasks, participants were asked to stand still 
with eyes open or closed on a firm or foam surface in a normal, 
comfortable standing position, lateral borders of the feet hip width 
Fig. 2. Schema of the timing of balance assessments and training sessions, with and without, vibrotactile balance feedback of trunk sway. The subjects were seen 3 
times a week over 4 weeks for assessments [1–8] and training, then once a week for assessments only [9–12] for a further over 4 weeks. A final assessment [13] took 
place 6 months later. 
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apart, and arms hanging alongside the trunk. The foam surface was 10 
cm high, 44 cm width and 204 cm long and had a density of 25 kg/m3. 
For eyes open stance tasks, patients were asked to focus on a point at eye 
height 5 m away. During one-legged tasks, patients chose their better leg 
to stand on. Stabilizing their raised leg against the standing leg was not 
allowed. All walking tasks (with eyes closed, with head pitching up and 
down, or walking over 4 low barriers) were measured over 3 m, except 
walking 8 m with eyes open. The barriers were 24 cm in height and 
spaced one meter apart. During all tasks patients were asked not to talk 
and a spotter stood next to them to aid in case of a loss of balance 
control. For the assessment sequences, each task was performed once 
and in training sequences, each task was repeated five times. Only 1 trial 
of each task was performed during the assessments as we wanted to 
avoid tiring the MS patients which we presumed would lead to greater 
balance variability [35]. Theoretically, it would have been possible to 
use the VTfb training trials for the assessments with VTfb. However, we 
decided to keep the assessment comparisons as similar as possible. Tasks 
were stopped if the patient lost balance, for example, needing to take a 
step during 2-legged stance trials,or if the non-stance foot touched the 
floor during 1-legged stance trials, or when the task was completed. 
Only data prior to the loss of balance was analysed. During the training 
and the assessment sequences, patients were requested to sway as little 
as possible. When the patients received VTfb of trunk sway, they were 
requested to try to avoid activating the vibrotactile transducers or to 
move away from the direction indicated by feedback if the VTfb was 
activated. 
2.6. Outcome measures 
For each task of the assessments, peak-to-peak and 90% ranges for 
pitch velocity (pv), pitch angle (pa), roll velocity (rv) and roll angle (ra) 
and duration (dur) were measured. Shortened durations, due to lost 
control of balance during a gait task, were not entered into the analysis 
in order to avoid such durations representing a fast task completion. We 
concentrated on one primary measure, a global balance control index 
(BCI) to compare balance control between assessments. The BCI is a 
single value which represents a summary of the results from several 
tasks. That is, the index combines peak-to-peak measures from several 
different tasks into one value. Thus, the BCI is an additive composite 
score based on measures from several tasks: From the task standing on 
two legs on foam with eyes closed (s2ecf) (2 * pv), for walking 8 tandem 
steps (tan8_pos) (1 * ra), for walking 3 m eyes closed (w3ec) (1.5 * pv +
20 * duration (dur)), for walking 3 m while pitching the head up and 
down (w3hp) (1.5 * pv). Task abbreviations are also listed in Table 2. 
That is 
BCI = 2*s2ecfpv + tan8ra + 1.5*w3ecpv + 20*w3ecdur + 1.5*w3hppv  
[36]. 
The basis for this selection of measures and coefficients in the BCI is a 
step-wise discriminant analysis described in Allum and Adkin [37] and 
Hegeman et al. [36] as a way to identify balance control deficits in 
Fig. 3. Mean balance control Index (BCI) values for the first assessment, 
labelled “baseline”, in comparison to subsequent assessments. A: for the as-
sessments with on-line feedback – labelled “feedback effect”, B: for the short 
term carry-over effect during training (assessments with no feedback present), 
and C: for the medium term carry-over effect after VTfb training ceased. The 
height of the column represents the mean population sample value for each 
assessment and the vertical bar on the column, the standard error of the mean. 
The upper 95% limit of BCI values for healthy control subjects of the same mean 
age (±5 years) as the study MS patients is shown by the horizontal arrows on 
the ordinates (data from Hegeman et al. [36]). The post-hoc p-values for the 
multilevel model comparison between assessment 1 and the assessment number 
noted below the column is listed above the columns. The p values for fixed 
effects are still significant (p ≤ 0.0125) in panels A, B and C after Bonferroni 
corrections for 4 comparisons (that is, for example, assessment 1 with 2, 4, 6, 
and 8). A linear regression line has been drawn through the BCI means over 4 
weeks and its coefficient (R) listed to the right the columns, except in C for 
which R was not significant. 
Table 2 
Order of stance and gait tasks for assessment and during training sessions.  
Task (and task abbreviations)  
1. Standing on 2 legs, eyes closed, 20 s (s2ec).  
2. Standing on 1 leg, eyes open, 20 s (s1eo).  
3. Standing on 2 legs, eyes open, on foam, 20 s (s2eof).  
4. Standing on 2 legs, eyes closed, on foam, 20 s (s2ecf).  
5. Tandem stance, eyes open, 30 s (tanS)  
6. 8 tandem steps, eyes open (position feedback) (tan8_pos).  
7. Walking 3 m while pitching the head up and down (w3hp).  
8. Walking 3 m, eyes closed (w3ec).  
9. Walking over 4 low barriers (barriers)  
10. Walking 8 m, eyes open (w8meo).  
11. 8 tandem steps, eyes open (velocity feedback) (tan8_vel).  
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peripheral vestibular loss patients in comparison to healthy controls. 
This combination of the selected balance outcome measures has also 
been shown to have a high accuracy in detecting MS patients with 
impaired balance control [34]. When this index revealed differences, 
90% ranges of all trunk sway measures and task durations were exam-
ined as secondary measures. 
Subjective balance impairment was assessed using the above 
mentioned DHI and MSWS-12 patient-reported outcome measures 
(PROMs) at beginning of each week when patients were seen weekly 
(weeks 1 to 8) and then just before the assessment at 6 months, in order 
to capture subjective carry-over effects. 
2.7. Statistical analysis 
We applied multilevel linear models to the data using the maximum 
likelihood method. Within the model, participant scores were defined to 
be dependent on the different assessment time points [38]. In order to 
allow effects to vary across entities, “participants” were set as random 
effects [38]. 
Posthoc data from assessment 1 was compared with the data for the 
subsequent assessments provided the factor “assessment time” was sig-
nificant (p ≤ 0.05). Data from the following groups of assessments was 
compared to the baseline assessment 1 to provide confirmation of the 
following hypotheses using:  
• Assessments 2, 4, 6, and 8 – to evaluate the assumed increasingly 
positive effect with time of on-line VTfb on balance control during 
the 4 week training period. Fig. 2 describes the organisation of the 
assessments.  
• Assessments 3, 5, 7 and 9 – to evaluate the assumed increasing 
positive effect with time of the short-term carry -over effect of VTfb 
training on balance control and PROMs during the 4 week training 
period.  
• Assessments 9, 10, 11, 12 – to evaluate the assumed decreasing 
medium-term carry-over effect of VTfb training on balance control 
and PROMs in the 4 weeks after VTfb training had ceased. Note that 
assessment 9 occurred 3 days after the last training and online VTfb 
assessment session and was also the first of the 4 weeks of assess-
ments post VTfb training.  
• Assessment 13 - to evaluate the assumed terminated long-term carry- 
over effect of VTfb training on balance control and PROMs 6 months 
after VTfb training had ceased. 
BCI values, mean trial duration, the mean of the 90% ranges for pv, 
pa, rv, and ra, and the mean PROM values were compared between 
assessments within the multilevel linear fixed effects model. Separately, 
comparisons between the balance measurements and PROM values of 
assessment 1 with those of assessment 13 (at 6 months post training) 
were performed with the Wilcoxon signed rank t-test. Because of the 
large time span (5 months) between assessments 12 and 13 we required 
that both within the multilevel model and the Wilcoxon signed rank t- 
test be significant when comparing assessment 13 with baseline 
(Assessment 1). The level of alpha was set at 5% for the fixed effects 
model. The subsequent post-hoc analyses were corrected for multiple 
comparisons using a Bonferroni correction. 
All analyses were performed in RStudio, Version 1.3.1073 [39]. For 
the multilevel models, the R-package “nlme”, Version 3.1-148 was used 
[40]. 
Table 3 
Statistical descriptives for Balance Control Index (BCI) values at baseline (assessment 1), during the 4 weeks of training (assessments 2 to 9, and 1 to 4 weeks and 6 
months after training ceased (assessments 9 to 13). The following abbreviations have been used: N stands for number of cases; sem for standard error of the mean; sd for 
standard deviation.  
N = 16 (except Ass 8 
= 15) 
Baseline Feedback effects 
BCI After 1 week of training After 2 weeks of training After 3 weeks of training After 4 weeks of training 
Assessment 
1 
Assessment 2 Assessment 4 Assessment 6 Assessment 8 
Mean 384 315 315 304 311 
Median 363 301 310 293 291 
sem 19.4 13.0 15.1 13.9 15.4 
sd 77.8 51.9 60.5 55.8 59.5 
Max-Min 545–284 417–252 452–226 424–220 450–236  




After 1 week of training 
Assessment 3 
After 2 weeks of training 
Assessment 5 
After 3 weeks of training 
Assessment 7 
After 4 weeks of training 
Assessment 9 
Mean 384 328 319 303 311 
median 363 325 323 293 304 
sem 19.4 16.2 14.6 11.0 12.5 
sd 77.8 64.7 58.5 44.0 50.1 
Max-Min 545–284 443–243 415–197 394–239 424–228   
N = 16 (except 11 & 12 =
15) 
Medium and long-term carry-over effects 
BCI Baseline 1 week after training 
ceased 
2 weeks after training 
ceased 
3 weeks after training 
ceased 
4 weeks after training 
ceased 
6 months after training 
ceased 
Assessment 1 Assessment 9 Assessment 10 Assessment 11 Assessment 12 Assessment 13 
Mean 384 311 323 319 314 346 
median 363 304 289 299 336 335 
sem 19.4 12.5 17.2 12.5 13.5 19.7 
sd 77.8 50.1 66.4 48.5 52.3 79.0 
Max- 
Min 
545–284 424–228 480–233 412–250 378–227 547–233  
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3. Results 
3.1. Improvements in balance scores 
Fig. 3A, B and C illustrate the effects of VTfb on the global balance 
control index (BCI) described in the methods section. Table 3 lists the 
statistical descriptives of the BCI values. The assessments when VTfb was 
present (Fig. 3A and Table 3) were associated with a significant reduc-
tion (improvement) in the BCI (p ≤ 0.0001) over the first 4 weeks of 
training compared to baseline measures. Almost all of the reduction 
(18%) occurred in the first week (Fig. 3A: BCI mean baseline value equal 
to 384.4 ± 19.4 sem compared to 314.5 ± 13.0 for assessment 2) as 
indicated by changes in intercept values of our statistical model (− 70 to 
− 76). Independently, the regression line in Fig. 3A (BCI = − 2.12×
+317, where x is weeks) also shows that there was a gradual reduction 
in mean BCI values over training weeks 2 through 4. 
Short-term carry-over effects, measured 3 days after a previous 
training with VTfb on Fridays (Fig. 3B and Table 3), were observed when 
balance control was tested without VTfb during the first 4 weeks. For 
these assessments, BCI values were in the first and second training week 
slightly larger (less reduced) than when tested with VTfb but decreased 
(improved) more rapidly (model intercept values changed from − 56 to- 
75, see also regression line (BCI = − 6.62× +332) in Fig. 3B) so that at 4 
weeks there was no difference between feedback and short-term carry- 
over effects (both 19% improvements). Concerning the medium term 
carry-over effects over the 4 weeks post VTfb training, the BCI values 
remained constant (no significant regression) with a value of ca. 312 
(19% improvement – see Fig. 3C). However, at 6 months post training 
the BCI value was not significantly less than baseline (345.9 ± 19.7 
(sem) see also Fig. 3C and Table 4). Our observations with a limited 
number of patients indicated that at 2 months the BCI was still signifi-
cantly lower baseline (296.1 ± 27.9, p = 0.05) but not at 4 months 
(337.6 ± 32.4 p > 0.05). 
Table 4 provides an overview of the significant improvements for 
each task variable when considering the feedback and carry-over effects. 
It can be noted by the density of the symbols that the feedback effect was 
stronger than for the medium term carry-over effects (trend p = 0.1 seen 
in a pair-wise proportionality test). The variables in order of roll angle, 
roll velocity and pitch angle were most often significant across feedback 
effects and less significant for medium-term carry-over effects, except 
for task duration which was most significant for the medium term carry- 
over effect (see totals of Table 4 in row labelled “total of 11”). The tasks 
in Table 4 are arranged in order of the number of significant variables 
per task (see totals in Table 4 in column labelled “total of 15”). Standing 
on one leg and other gait tasks, emphasising periods of one-legged 
stance (walking tandem steps and walking over low barriers), show 
the highest number of significant variables, standing on 2 legs with eyes 
closed and walking 8 m with eyes open, the least. Table 4 also indicates 
which tasks contributed most to the improvement in the BCI, namely: 
tandem steps, walking 3 m with head pitching and standing on 2 legs, 
eyes closed on foam. 
3.2. Differences between angle and angular velocity feedback 
We examined the influence of angle and angular velocity based VTfb 
on tandem gait expecting to find that angle feedback improved roll angle 
more, and angular velocity feedback roll angular velocity more. As 
Figs. 4 and 5 illustrate there was no difference between the two types of 
feedback for the feedback and carry-over effects. Both improved roll 
angles and roll velocity equally with the greatest improvement occur-
ring when VTfb was present (on-line) rather than as a carry-over effect 
(Figs. 4 and 5). 
3.3. Patients’ subjective assessments of balance capabilities 
The MSWS-12 and DHI questionnaires were used to assess patients’ 
subjectively perceived balance capabilities. The analysis of data from 
both PROMs showed a significant improvement (lower scores), both 
during and after VTfb training (see Figs. 6 and 7, Table 5). The effect of 
VTfb training on the MSWS-12 scores was constantly small (ca. 9%) but 
statistically significant with respect to baseline (assessment 1). 
Interestingly, the effect of VTfb on reducing DHI scores was initially 
similarly low (11.5%). This effect improved showing decreased DHI 
values progressively over the 4 weeks of training (model intercept values 
and linear regression of mean values, (DHI = − 2.46× +30.1, where x 
equals weeks, R = 0.92, p = 0.05) to reach an improvement of 32% at 4 
weeks as noted at assessment 9 (see Fig. 7A, B and Table 5). These scores 
were not, however, significantly correlated with sway measures. For 
Table 4 
Overview of trunk sway variables (90% ranges) and trial durations which had 2 or more Wilcoxon t-test values with a significance p < 0.05 for each of 5 assessment 
comparisons (roll and pitch angle, roll and pitch velocity, duration) with baseline assessment 1. That is, for example, roll angle, for assessment 1 was compared with 
roll angle for feedback effect assessments 2, 4, 6, 8, short term carry-over effect assessments 3, 5, 7, 9, and medium term carry-over effect assessments 9, 10, 11, 12. 
Sway angle, sway angular velocity and duration variables fulfilling this criterion are marked ▴. Thus for roll angle feedback assessments, 2 of the comparisons of 1vs2, 
1vs4, 1vs6 and 1vs8 would need to be significant in order to be marked in the table with ▴. The tasks are arranged in order the number of times this criterion is fulfilled 
across assessments (see end column labelled “Total of 15”). The number of times the same criterion was fulfilled per variable and comparison set is listed in the lowest 
row labelled “Total of 11”. The following abbreviations have been used: vel, velocity; Dur, Duration; eo, eyes open; ec, eyes closed; s1, stance on 1 leg; s2, stance on 2 
legs; tan8, 8 tandem steps; _vel, with angular velocity feedback; _pos, with angle position feedback; wob, walking over low barriers; w3, walk 3 m; w8, walk 8 m; hp., 
head pitching up and down; tanS, tandem stance; f, foam surface. Comparisons of duration were not made for the following stance trials because of ceiling effects in the 
data tanS, s2ecf, s2ec and s2eof.  
Task Feedback effect (assessments 2, 4, 6, 8) Short term carry-over effect (assessments 3, 5, 7, 
9) 





























tan8_vel ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ 15 
s1eo ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴ ▴   ▴ ▴ 13 
tan8_pos ▴ ▴ ▴ ▴ ▴ ▴ ▴   ▴ ▴ ▴   ▴ 11 
tanS ▴ ▴ ▴ ▴  ▴ ▴ ▴ ▴     ▴  9 
wob ▴ ▴ ▴ ▴  ▴    ▴ ▴  ▴  ▴ 9 
w3hp ▴ ▴ ▴   ▴ ▴   ▴ ▴    ▴ 8 
s2ecf ▴ ▴ ▴   ▴ ▴ ▴     ▴ ▴  8 
w3ec ▴  ▴  ▴ ▴    ▴ ▴    ▴ 7 
s2ec ▴     ▴  ▴ ▴    ▴ ▴  6 
w8eo ▴  ▴  ▴          ▴ 4 
s2eof ▴ ▴         ▴  ▴   4 
Total of 
11 
11 8 9 5 5 9 6 5 4 6 7 2 5 5 7   
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example, for the task with most improvement, standing on 1 leg, roll 
angle had a correlation of 0.32 with the DHI score after 4 weeks of 
training. In the weeks post VTfb training, DHI scores increased again, 
but nonetheless still with a significant improvement at 4 weeks of 
follow-up (26%, assessment 12) and at 6 months, assessment 13 (29%) 
(Fig. 7B and Table 5) with respect to baseline (assessment 1). 
4. Discussion 
This study explored the characteristics of the improvement in bal-
ance control when MS patients were provided sensory augmentation in 
the form of vibrotactile feedback (VTfb) of trunk sway. Apart from 
providing interesting scientific information on the effect of sensory 
augmentation on balance control for MS patients, the knowledge gained 
on these characteristics is crucial for clinical planning of rehabilitation 
strategies based on VTfb. Examining the direct feedback effects of VTfb, 
there was little difference in the changes in global balance scores when 
1, 2, 3 or 4 weeks of training were provided (Fig. 3A). However, the 
short-term carry-over effect reached its best improvement at 4 weeks 
(Fig. 2B). Furthermore, a similar best improvement was reached in pa-
tients’ DHI scores at 3 weeks (Fig. 7A). It would seem important to 
include this subjective rating of perceived balance capabilities when 
considering the length of a sensory augmentation training period. Most 
studies using VTfb have chosen to use training durations of 6 weeks 
similar to those of vestibular rehabilitation therapy [25,41,42] without 
consideration of possible criteria for selection of the optimal training 
duration. A rapid early improvement followed by a slower learning 
phase as we observed is typical of motor skill learning [43]. Based on the 
best improvement in short-term carry-over effects in balance and DHI 
scores, we would recommend using 3 weeks of VTfb training twice per 
week. 
One important outcome of this study is the dominance of improve-
ment in roll angle values both during training and after completion of 
the training (Table 3). Moreover, the tasks, which showed most 
improvement, were those likely to be most affected by roll instability: 
standing on one leg, walking over low barriers, walking tandem steps 
and tandem stance (Table 3). That is, the improvement was present for 
gait tasks with extended single stance phases. This finding supports 
previous work that patients with MS frequently present a lower-leg 
asymmetry in the form of muscle weakness or sensory loss [44,45], 
which results in lateral instability when tested with dynamic posturog-
raphy (Tang, Allum, Yaldizli et al., unpublished observations). In other 
patient groups with asymmetrical disease effects (e.g. those with Par-
kinson’s disease) roll angle and pitch velocity also showed the most 
improvement with VTfb training [46]. All these findings suggest that a 
simplification of the VTfb procedure providing only roll feedback might 
be worthwhile considering. When this was attempted with young 
healthy subjects, the reductions in stance and gait roll angles were 
greater with roll only versus pitch only VTfb [47]. Specifically, for the 
task of standing on one leg task the reduction in roll sway was greater for 
roll sway only VTfb than the reduction in pitch sway for pitch only VTfb. 
Fig. 4. Mean population sample values of the 90% range of trunk roll sway 
angle for the task of walking 8 tandem steps with either angle or angular ve-
locity feedback. The height of the columns represents the mean population 
values and the vertical bars on the columns the standard error of the mean. The 
value for the first, baseline, assessment is shown as a filled column on the left. 
A: On-line feedback effects for assessments 2, 4, 6, and 8 for which either po-
sition or velocity feedback was provided. B Medium-term carry-over effects 
observed in assessments 9, 10, 11 and 12 in the 4 weeks subsequent to feedback 
training. The p-value, prior to a Bonferroni correction of the mean value for 
each assessment with respect to baseline, is noted on the columns. For the p- 
value to remain significant after the Bonferroni correction, p must be ≤0.01 
prior to correction. ns stands for not significant. 
Fig. 5. Mean population sample values of the 90% range of trunk roll sway 
angular velocity for the task of walking 8 tandem steps with either angle or 
angular velocity feedback. A: On-line feedback effects for assessments 2, 4, 6, 
and 8 for which either position or velocity feedback was provided. B Medium- 
term carry-over effects observed in assessments 9, 10, 11 and 12 in the 4 weeks 
subsequent to feedback training. Details of the figure are provided in the legend 
to Fig. 3. 
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Thus, further studies should explore the efficacy of providing only roll 
feedback in comparison to the multi-directional roll and pitch feedback 
(8 directions) used in this study. 
The question of the duration of the carry-over effect once training 
had stopped is linked to the question whether to rely solely on the 
feedback effect and not on the carryover effect for improving balance in 
MS patients. That is, in the former case, the patient would be assumed to 
wear the device continuously. Although a carry-over effect was seen up 
to 2 months post training, the effect was not as strong as the feedback 
effect (see Tables 3 and 4). Our carry-over effect is less pronounced than 
that observed by Bao et al. [42] in their pilot study on vestibular loss 
patients, and more pronounced than that observed in other pilot studies 
on the elderly and patients with uncompensated unilateral vestibular 
loss [16]. In the study of Bao et al. [42] patients received a more intense 
and longer training protocol – 3 sessions a week for 8 weeks – which may 
have influenced the carry-over effect. In another study of carry-over 
effects, Brugnera et al. [48] showed a more significant improvement 
in the medium term carry-over effect for condition 6 (eyes closed on a 
sway-referenced platform) of the Equitest system which is an easier but 
comparable to the task standing eyes closed on foam task used in the 
current study [49]. However, there are also a number of differences 
between these studies, 10 vs 8 days of training, 6 vs 11 trained tasks 
respectively for the current study which could have influenced the re-
sults too. Nonetheless it may concluded from these studies that if pa-
tients did not choose to use the VTfb continuously, an alternative option 
Fig. 6. Changes in the MSWS-12 questionnaire values during (A) and after (B) 
feedback training. The height of the column represents the mean value and the 
vertical bar on the column, the standard error of the mean. The significance 
(prior to Bonferroni corrections) of the difference of the means with respect to 
assessment 1 values (baseline) is indicated by asterisks on the columns. For the 
mean comparison to remain significant after Bonferroni correction p needed to 
be ≤0.01. There were no regression significant trends observed in mean MSWS 
values over weeks 1 to 4 during and after feedback training. Quest. stands for 
questionnaire. 
Fig. 7. Changes in DHI questionnaire values during (A) and after (B) feedback 
training. The height of the column represents the mean value and the vertical 
bar on the column, the standard error of the mean. The significance, prior to 
Bonferroni corrections) of the difference of the means with respect to assess-
ment 1 values (baseline) is indicated by symbols above the columns in A, and by 
text in B. For the mean comparison to remain significant after Bonferroni 
correction p needed to be ≤0.01. There were significant trends in the re-
gressions observed in MSWS values over weeks 1 to 4 during (R = 92, 
decreasing values over time) and after (R = 0.71, increasing values) feed-
back training. 
Table 5 
Statistical descriptives for MSWS and DHI questionnaires at baseline (assessment 
1), 1 week after training ceased (assessment 9), and 6 months after VTfb training 
ceased (assessment 13). DHI stands for Dizziness Handicap Inventory score; 
MSWS-12 for MS, 12 question, walking score.  
MSWS- 
12 
Baseline 1 week after training 
ceased 




Assessment 9 Assessment 13 
Mean 30.3 26.0 24.8 
Median 29.0 25.0 20.0 
sem 2.6 2.6 3.0 
sd 10.2 10.2 10.1 
Min 15 14 12 
Max 46 43 43 
Range 31 29 31  
DHI Baseline 1 week after training 
ceased 




Assessment 9 Assessment 13 
Mean 31.6 21.5 22.4 
median 28.0 16.0 28.0 
sem 4.2 3.9 4.1 
sd 16.9 15.2 13.6 
Min 8 2 6 
Max 64 52 46 
Range 58 50 40  
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would be to train them for 3 weeks and them to return for further 
training 2 months after training had stopped and the carry-over effects 
have “worn-off”. Improving the latter option should be explored in 
future research. Improving the carry-over effect is a highly relevant 
aspect for those patients preferring not to wear a feedback device 
continuously. 
A further interesting question is whether trunk angular or angular 
velocity feedback should drive the VTfb. Most of the previous studies 
which focussed on this question have suggested that a combination of 
the two would be optimal for control of stance, as above 0.5 Hz there is, 
based on modelling procedures, an increase of sway with solely angular 
position feedback [21,50]. Unfortunately, a theoretical framework 
examining this question for gait is missing. In our study we chose to use 
position feedback for stance trials and velocity feedback for gait trials 
based on previous work with chronic unilateral vestibular loss patients 
[51]. As recommended by Loughlin et al. [21] we set the position and 
velocity thresholds individually. We attempted to determine the more 
optimal mode of feedback was by using both position and velocity 
driven VTfb for tandem gait trials. Tandem gait can be considered a 
combined stance and gait task. Our results indicated that both modes of 
feedback were equally effective in reducing trunk sway when VTfb was 
present (Figs. 3 and 4, Table 4). However, carry-over effects for pitch 
were slightly greater for velocity VTfb. As we only tested one gait task, 
tandem steps, for differences between position and velocity driven VTfb, 
future studies should determine if combining the 2 modes of feedback as 
others have done [42,50] leads to improved effects for all gait tasks, 
further if the combination is disease specific. For example, MS patients 
may require a different feedback combination of position and velocity 
feedback from that of vestibular loss patients due to the former patient 
group having a proprioceptive loss. 
We mounted the VTfb system within a head band. The feedback 
signal during gait was the pitch and roll angular velocity of the lower 
trunk (lumbar 1–3) roughly equivalent to the movement of the centre of 
mass. While such a system has the advantage of providing a rapid 
feedback to the CNS, being on the head, it has the disadvantage that the 
subject has to correct for the yaw rotation of the head movement when 
using the VTfb to drive balance control signals in the pitch and roll 
planes. A similar transformation must be employed when the CNS uses 
vestibular signals to drive balance control of the body’s centre of mass. 
In fact, when subjects were asked to walk over low barriers, a task that 
involves large yaw (twisting about the body’s longitudinal axis) rota-
tions, the improvements were much greater for this task than when yaw 
rotations were less as during walking 8 m (Table 4), indicating that MS 
patients were able to perform the necessary spatial transformation of 
VTfb signals. Interestingly, the body’s yaw rotations have not been 
coded into VTfb devices to date. Thus, it remains an open question 
whether this additional information would further improve balance 
control for MS patients. 
The current study has a number of limitations. We are aware that MS 
patients can have a variety of neurological deficits (see Table1). Thus 
finding MS patients showing the same neurological deficits is difficult, as 
each case seems to have its own individual course. Nonetheless, there is 
a common pattern of neurological deficits affecting most MS patients, 
constituting of variable degrees of spastic paraparesis as was present in 
the majority of our patients. Secondly, our control cross-over study 
comparing the effects of VTfb with that of training the same tasks 
without VTfb had fewer subjects, 10, compared to 16 in the current 
study. It is possible that similar trends in balance improvements for the 
two studies would not have been observed with 16 subjects in the 
control study. Furthermore, 2 gait tasks (walking with head pitching 
with velocity VTfb and walking 8 tandem steps with position VTfb) did 
not feature in the control study which was designed to act as a control 
study for the current study as well as a control for other planned studies. 
Thus future RCT studies should take these factors into account. We were 
not able to demonstrate significant correlations between trunk sway 
measures and DHI scores, even for the variables and tasks (roll angle 
during standing on 1 leg or during tandem gait) at the time point of 3 
weeks of training when we noted the most improvement with VTfb. 
Previous studies [33] had noted a correlation for MS subjects not 
receiving VTfb, however, for a greater number of subjects, a total of 37, 
and a greater range of EDSS scores (1.0 to 4.5) compared to the range of 
this study (2.5 to 4.0). Thus future studies should consider increasing the 
range of EDSS scores. Also, we did not collate information on the 
balance-oriented physiotherapy received by the patients prior to and 
during the current study which might have influenced our results. 
Another limitation of the current study is longer duration of training 
we compared to that of our control study [22]. We designed the current 
study to determine short-term and medium-term effects of VTfb 
training, and noted that the initial (1st week) short-term feed-back ef-
fects were significantly greater than control training effects determined 
in our previous cross-over study [22]. Thus the question arises whether 
our control study should have had a longer period of training under the 
assumption that a longer period of training might have brought greater 
improvements equaling those obtained with VTfb. In the current study, 
we found a rapid initial short-term feedback-effect as in our previous 
studies [22] accompanied by a slow improvement in the short-term (first 
4 weeks) feedback and carry-over effects and followed by slow reduction 
of the medium-term (second 4 weeks) carry-over effect post training. If 
the short-term carry-over effects were equally effective for training of a 
control group without VT feedback, then we should have seen that the 
carry-over effects during the first 4 weeks of training were stronger than 
the effect of feedback because, presumably, these effects (carry-over 
from feedback training and training due to the assessments without 
feedback) would then have been additive effects. We saw no evidence 
for this in the short-term carry-over effects but it should be noted that 
separating these additive effects is complicated. A control group 
receiving no VTfb, only training for a period of 4 weeks might have 
brought more information on the magnitude of training and VTfb carry- 
over effects compared to a control group. Another question that arises is 
if the short-term carry-over effect would have been larger if we had 
tested for this immediately after the VTfb assessments rather than 3 days 
later. We chose this procedure for 2 reasons. Firstly, we wanted to avoid 
fatiguing the MS patients, and secondly our primary interest was in the 
medium and long-term carry-over effects in order to determine when 
patients should return for further training once these later effects have 
“worn-off”. 
In this study we specifically excluded some difficult tasks such as 
walking up and down a set of stairs without handrails as we had noted in 
previous studies [34] that these tests were too difficult for most MS 
patients with EDSS scores of 3 and higher to perform. It is an open 
question whether the approach taken by Bao et al. [42] to adapt the 
exercise regime to the patient’s balance abilities, providing more chal-
lenging exercises for those with superior balance control, would have led 
to different results to those described in the current study. 
In conclusion, a 3 week VTfb training program demonstrated the 
most significant improvement in the short term carry-over effect on the 
balance control of MS patients. An additional week of training did not 
result in further improvements to balance control. Similar results were 
obtained from the patients’ subjectively assessed balance capabilities 
(PROMs). The carry over effects of VTfb on balance control lasted 2 
months. At this time, patients would need to receive further training if 
not using the VTfb system continuously. We found most improvement 
both in terms of body sway angles and durations for stance and gait tasks 
involving 1-legged stance phases. A practical example is walking over 
low barriers. We found no difference between using velocity or position 
VTfb for the limited number of tasks we explored. Patients seemed 
capable of adapting to both types of feedback. 
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